{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:58Z","timestamp":1760028298648,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.7759\/cureus.87104","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:15:27Z","timestamp":1751375727000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19-Associated Mucormycosis: Outcomes From a Tertiary Care COVID-19 Hospital"],"prefix":"10.7759","author":[{"given":"Vijaya Kumar","family":"Lukka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KVS","family":"Kumar Chowdary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri Lekha","family":"Bandaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kolli","family":"Naga Saritha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54 Suppl 1","author":"Ibrahim AS","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012, 54 Suppl 1:S16-22. 10.1093\/cid\/cir865","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab190","article-title":"COVID-19-associated mucormycosis presenting to the emergency department-an observational study of 70 patients","volume":"114","author":"Ramaswami A","year":"2021","unstructured":"Ramaswami A, Sahu AK, Kumar A, et al.. COVID-19-associated mucormycosis presenting to the emergency department-an observational study of 70 patients. QJM. 2021, 114:464-70. 10.1093\/qjmed\/hcab190","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12897","article-title":"Mucormycosis-a clinicoepidemiological review of cases over 10\u00a0years","volume":"62","author":"Manesh A","year":"2019","unstructured":"Manesh A, Rupali P, Sullivan MO, Mohanraj P, Rupa V, George B, Michael JS. Mucormycosis-a clinicoepidemiological review of cases over 10\u00a0years. Mycoses. 2019, 62:391-8. 10.1111\/myc.12897","journal-title":"Mycoses"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.06.017","article-title":"Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study","volume":"29","author":"Manesh A","year":"2023","unstructured":"Manesh A, Devasagayam E, Bhanuprasad K, et al.. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study. Clin Microbiol Infect. 2023, 29:1298-305. 10.1016\/j.cmi.2023.06.017","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal R","year":"2021","unstructured":"Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, Kumar A. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021, 64:1452-9. 10.1111\/myc.13338","journal-title":"Mycoses"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-022-00440-2","article-title":"Mortality-related risk factors for coronavirus disease (COVID-19)-associated mucormycosis: a systematic review and meta-analysis","volume":"16","author":"Ostovan VR","year":"2022","unstructured":"Ostovan VR, Tabrizi R, Bazrafshan H, et al.. Mortality-related risk factors for coronavirus disease (COVID-19)-associated mucormycosis: a systematic review and meta-analysis. Curr Fungal Infect Rep. 2022, 16:143-53. 10.1007\/s12281-022-00440-2","journal-title":"Curr Fungal Infect Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin22.099","article-title":"Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period","volume":"60","author":"Cherian LM","year":"2022","unstructured":"Cherian LM, Varghese L, Rupa V, et al.. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period. Rhinology. 2022, 60:427-34. 10.4193\/Rhin22.099","journal-title":"Rhinology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, et al.. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021, 27:2349-59. 10.3201\/eid2709.210934","journal-title":"Emerg Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07544-y","article-title":"COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes","volume":"280","author":"Moorthy A","year":"2023","unstructured":"Moorthy A, Nayak T, Bachalli PS, et al.. COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes. Eur Arch Otorhinolaryngol. 2023, 280:713-21. 10.1007\/s00405-022-07544-y","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al.. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021, 69:1670-92. 10.4103\/ijo.IJO_1565_21","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.08.037","article-title":"Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic","volume":"111","author":"Bhanuprasad K","year":"2021","unstructured":"Bhanuprasad K, Manesh A, Devasagayam E, et al.. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic. Int J Infect Dis. 2021, 111:267-70. 10.1016\/j.ijid.2021.08.037","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2012.01.002","article-title":"Diabetes and mucormycosis: a complex interplay","volume":"38","author":"Rammaert B","year":"2012","unstructured":"Rammaert B, Lanternier F, Poir\u00e9e S, Kania R, Lortholary O. Diabetes and mucormycosis: a complex interplay. Diabetes Metab. 2012, 38:193-204. 10.1016\/j.diabet.2012.01.002","journal-title":"Diabetes Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.03.008","article-title":"COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases","volume":"29","author":"\u00d6zbek L","year":"2023","unstructured":"\u00d6zbek L, Top\u00e7u U, Manay M, et al.. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023, 29:722-31. 10.1016\/j.cmi.2023.03.008","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature","volume":"186","author":"Garg D","year":"2021","unstructured":"Garg D, Muthu V, Sehgal IS, et al.. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021, 186:289-98. 10.1007\/s11046-021-00528-2","journal-title":"Mycopathologia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis MS","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003, 362:1828-38. 10.1016\/S0140-6736(03)14904-5","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy A","year":"2021","unstructured":"Moorthy A, Gaikwad R, Krishna S, et al.. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021, 20:418-25. 10.1007\/s12663-021-01532-1","journal-title":"J Maxillofac Oral Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac044","article-title":"Risk factors for COVID-19 associated mucormycosis in India: a case control study","volume":"60","author":"Patel AK","year":"2022","unstructured":"Patel AK, Bakshi H, Shah K, Patel S, Patel T, Patel K, Patel KK. Risk factors for COVID-19 associated mucormycosis in India: a case control study. Med Mycol. 2022, 60:10.1093\/mmy\/myac044","journal-title":"Med Mycol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13435","article-title":"Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: a single centre experience from Pune, Western India","volume":"65","author":"Dravid A","year":"2022","unstructured":"Dravid A, Kashiva R, Khan Z, et al.. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: a single centre experience from Pune, Western India. Mycoses. 2022, 65:526-40. 10.1111\/myc.13435","journal-title":"Mycoses"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23912","article-title":"Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence","volume":"123","author":"Turner JH","year":"2013","unstructured":"Turner JH, Soudry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope. 2013, 123:1112-8. 10.1002\/lary.23912","journal-title":"Laryngoscope"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379073-covid-19-associated-mucormycosis-outcomes-from-a-tertiary-care-covid-19-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:15:28Z","timestamp":1751375728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379073-covid-19-associated-mucormycosis-outcomes-from-a-tertiary-care-covid-19-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.87104","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}